6Thanendrarajan S, Kim Y, Schmidt - Wolf I. New adoptive immunotherapy strategies for solid tumours with CIK cells [ J ]. Expert Opin Biol Ther,2012,12 (5) :565 - 572.
8Schmidt-Wolf IG,Negrin RS,Kiem HP,et al.Use of a SCID Mouse/Human lymphoma model to evaluate cytokine.Induced killer cells with potent antitumor cell activity[J].Exp Med,1991,174:139.
9Gunzer M,Janich S,Varga G,et al.Dendritic cells and tumor immunity[J].Semin Immunol,2001,13(5):291-302.
10Sehmidt - Wolf IG, Lefterova P, Mehta BA, et al. Pheno typic char- acterization and identification of effector cells involved in tumor cell recognition of cytokine O induced killer cells [ J ]. Exp Hematol , 1993,21 (13) :1673 - 1679.
5Braner T, Htiser DF. Intercellular communieation anti Tumor Inva- sion in the Petri Dish [ J ]. ALTEX, 1988,5 ( 2 ) :4 - 17.
6Tran Cao HS, McElroy M, Kaushal S, et al. hnaging of the interaction of cancer cells and the lymphatic system [ J]. Adv Drug Deliv Rev, 2011,63(10 - 11) :886 -889.
7Geiger C, Nssner E, Frankenberger B, et al. Harnessing innale and adaptive immunity for adoptive cell therapy of renal cell carcinom [ J ]. J Mol Med(Berl) ,2009,87 ( 6 ) :595 - 612.
8Yang L, Ren B, Li H,et al. Enhanced antitumor eftcts of DC-activa- ted CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients [ J ]. Cancer hnmunol lrnmunoth- er,2013,62( 1 ) :65 -73.
9Wank R, Song X, Gu S, et al. Benefits of a continuous therapy forcancer patients with a novel adoptive cell therzpy by cascade prim- ing(CAPRI) [ J ]. Immunotherapy ,2014,6 (3) :269 - 282.
10Wang YF, Kunda PE,Lin JW, et al. Cytokine-induced killer cells co- cultured with complete tumor antigen-loaded dendritic cells, have enhancedselective cytotoxicity on carboplatin-resistant retinoblastoma cells [ J]. Oncol Rep,2013,29 (5) : 1841 - 1850.
